The biotech investor’s bible
An investment consultant, formerly a journalist who reported on the emergence of recombinant DNA technology, discusses the maturing biotech sector from new investment strategy and scientific/ technological perspectives. Appendices include a breakdown of 185 major biotech companies by market cap and...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Kirja |
| Kieli: | Undetermined |
| Julkaistu: |
New York
John Wiley & Sons
2001
|
| Aiheet: | |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
| Thư viện lưu trữ: | Trung tâm Học liệu Trường Đại học Cần Thơ |
|---|
| Yhteenveto: | An investment consultant, formerly a journalist who reported on the emergence of recombinant DNA technology, discusses the maturing biotech sector from new investment strategy and scientific/ technological perspectives. Appendices include a breakdown of 185 major biotech companies by market cap and tier, resources, and a glossary of biotech terms. |
|---|